Stay updated with breaking news from Factmr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FactMR: Animal Model Market Driven by Developments in Pharmaceutical and CRISPR Genetic Research, Opines Fact.MR Leading research organizations are investing increasingly in the use of advanced animal models for CRISPR and microinjection applications for long-term growth opportunities. NEW YORK, NY / ACCESSWIRE / April 14, 2021 / Fact.MR: The global revenue of animal model market will register a steady rate of growth through 2031, following substantial impetus emerging from drug and vaccine development endeavors. Fact.MR s latest study provides key animal model market statistics and actionable insights. The substantial rise in myriad novel therapies and drugs supported by studies on multiple animal species coupled with the growing prevalence and awareness about genetic disorders is expected to be the primary driver for market growth. Studies on human physiology will also contribute to demand for animal models. ....
FactMR: Nutraceutical Supplements Market Driven by Value-Added Wellness Objectives; Coronavirus Threat Boosts Consumption: Fact.MR Manufacturers lay emphasis on clean label and organic formulations along with personalized nutrition objectives to appeal to a wider consumer demographic. NEW YORK, NY / ACCESSWIRE / April 13, 2021 / Nutraceutical supplements in recent years are witnessing a strong rise in consumption, driven by growing consumer interest and awareness towards healthy and balanced dietary requirements. According to market research firm Fact.MR, increasing investments by key stakeholders towards personalized medicine and nutrition, and the growing interest for natural ingredients are emerging as major drivers for the nutraceutical supplements market. Consequently, the global nutraceutical supplements market is estimated to expand at around 6% CAGR over the forecast period (2021-2031). ....
Supported by evolving consumer preferences towards healthy diets, kenaf seed oil is gaining attention as a viable cooking oil, in addition to positive cancer research outcomes. ROCKVILLE, MD / ACCESSWIRE ....
Share this article Share this article NEW YORK, March 15, 2021 /PRNewswire/ Promising collaborations and partnerships to foster catalyst carrier sales combined with the extensive application in petrochemicals and pharmaceuticals are expected to act as beacons for the global catalyst carrier growth through 2021 and beyond, forecasts a pipeline study on the landscape by award winning consulting firm Fact.MR. According to Fact.MR, the market is poised to witness a moderate growth in the upcoming years. Various innovations and research & development activities from end-user industries such as petrochemicals and oil & gas is expected to witness a robust growth during the forecast period. For instance, according to Department of Energy, demand from petrochemical and oil & gas industry comes from the extensive usage in petroleum refining and catalytic cracking hydro-processing. Hence, advancing the sales for catalyst carrier. ....
FactMR: Treatment-Resistance Depression Treatment Making Advances: Study Initiatives undertaken to spread awareness on mental health will fuel demand for treatment-resistance depression treatment NEW YORK, NY / ACCESSWIRE / March 10, 2021 / Market research firm Fact.MR ongoing study presents bullish outlook on the treatment-resistance depression treatment market. As per the World Health Organization s (WHO s) factsheet, more than 264 million people worldwide of various age groups suffer from depression. Coupled with this, the prevalence of treatment-resistant depression is peaking, especially in America and several countries across Europe. Treatment-resistant depression (TRD) continues to be one of the highly neglected public health issue. A BMC Psychiatry study has found that treatment resistance is common among patients identified with major depressive disorders. Against this backdrop, the demand for treatment-resistance depression treatment is poised to surge. ....